Takeda Pharmaceutical (TAK) Inventory Average: 2019-2025

  • Takeda Pharmaceutical's Inventory Average rose 3.34% to $8.1 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $8.1 billion, marking a year-over-year increase of 3.34%. This contributed to the annual value of $8.2 billion for FY2025, which is 4.40% up from last year.
  • As of Q1 2025, Takeda Pharmaceutical's Inventory Average stood at $8.1 billion, which was up 3.34% from $7.8 billion recorded in Q1 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Inventory Average peaked at $8.1 billion during Q1 2025, and registered a low of $7.0 billion during Q1 2021.
  • Over the past 3 years, Takeda Pharmaceutical's median Inventory Average value was $7.8 billion (recorded in 2024), while the average stood at $7.8 billion.
  • Its Inventory Average has fluctuated over the past 5 years, first declined by 8.03% in 2021, then grew by 5.56% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Inventory Average (Quarterly) stood at $7.0 billion in 2021, then increased by 2.59% to $7.2 billion in 2022, then climbed by 2.32% to $7.4 billion in 2023, then increased by 5.56% to $7.8 billion in 2024, then increased by 3.34% to $8.1 billion in 2025.
  • Its last three reported values are $8.1 billion in Q1 2025, $7.8 billion for Q1 2024, and $7.4 billion during Q1 2023.